West Announces Second Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
West Pharma (WST) Tops Q2 EPS by 3c; Raises Outlook
July 28, 2016 7:34 AM EDTWest Pharma (NYSE: WST) reported Q2 EPS of $0.59, $0.03 better than the analyst estimate of $0.56. Revenue for the quarter came in at $388 million versus the consensus estimate of $384.58 million.
GUIDANCE:
West Pharma sees FY2016 EPS of $2.15-$2.25, versus prior guidance of... More
